Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:S40-S44
Published online before print December 8, 2008, doi: 10.1161/STROKEAHA.108.533638
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3_suppl_1/S40    most recent
STROKEAHA.108.533638v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iadecola, C.
Right arrow Articles by Capone, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iadecola, C.
Right arrow Articles by Capone, C.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Lacunes
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2009;40:S40.)
© 2009 American Heart Association, Inc.


Vascular Cognitive Impairment

Threats to the Mind

Aging, Amyloid, and Hypertension

Costantino Iadecola, MD; Laibaik Park, PhD Carmen Capone, PhD

From the Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York.

Correspondence to C. Iadecola, MD, Division of Neurobiology, Weill Medical College of Cornell University, 411 East 69th Street; KB410, New York, NY 10021. E-mail coi2001{at}med.cornell.edu

Aging, Alzheimer disease, and hypertension, major determinants of cognitive dysfunction, are associated with profound alterations in the structure and function of cerebral blood vessels. These vascular alterations may impair the delivery of energy substrates and nutrients to the active brain, and impede the clearance of potentially toxic metabolic byproducts. Reactive oxygen species derived form the enzyme NADPH oxidase are key pathogenic effectors of the cerebrovascular dysregulation. The resulting alterations in the homeostasis of the cerebral microenvironment may lead to cellular dysfunction and death and to cognitive impairment. The prominent role that cerebrovascular oxidative stress plays in conditions associated with cognitive impairment suggests new therapeutic opportunities to counteract and, possibly, reverse the devastating effects of cerebrovascular dysfunction on the brain.


Key Words: dementia • VCI




This article has been cited by other articles:


Home page
StrokeHome page
S. Black and C. Iadecola
Vascular Cognitive Impairment: Small Vessels, Big Toll: Introduction
Stroke, March 1, 2009; 40(3_suppl_1): S38 - S39.
[Full Text] [PDF]